MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/450/0.01/20.12.24 Share Price

Warrant

DE000MB33RH8

Market Closed - Börse Stuttgart 12:12:17 28/06/2024 am IST
0.7 EUR +4.48% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/450/0.01/20.12.24
Current month-4.11%
1 month-23.08%
Date Price Change
27/24/27 0.7 +1.45%
26/24/26 0.69 +2.99%
25/24/25 0.67 -2.90%
24/24/24 0.69 +1.47%
21/24/21 0.68 -5.56%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 12:12 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN MB33RH
ISINDE000MB33RH8
Date issued 01/02/2023
Strike 450 $
Maturity 20/12/2024 (176 Days)
Parity 100 : 1
Emission price 1.49
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.77
Lowest since issue 0.44
Delta0.73x
Omega 4.575
Premium7.03x
Gearing6.28x
Moneyness 1.098
Difference Strike -43.96 $
Difference Strike %-9.77%
Spread 0.03
Spread %4.00%
Theoretical value 0.7350
Implied Volatility 35.41 %
Total Loss Probability 35.84 %
Intrinsic value 0.4107
Present value 0.3243
Break even 528.67 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
494 USD
Average target price
564.1 USD
Spread / Average Target
+14.21%
Consensus